$INGN
Inogen Inc

2017 Q3 Form 10-Q Financial Statement

#000156459017022249 Filed on November 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $69.03M $54.40M
YoY Change 26.89% 33.41%
Cost Of Revenue $35.90M $29.30M
YoY Change 22.53% 82.6%
Gross Profit $33.17M $25.10M
YoY Change 32.15% 29.55%
Gross Profit Margin 48.05% 46.14%
Selling, General & Admin $23.50M $18.40M
YoY Change 27.72% 26.5%
% of Gross Profit 70.85% 73.31%
Research & Development $1.400M $1.400M
YoY Change 0.0% 25.45%
% of Gross Profit 4.22% 5.58%
Depreciation & Amortization $2.940M $3.420M
YoY Change -14.04% -3.93%
% of Gross Profit 8.86% 13.63%
Operating Expenses $24.80M $19.70M
YoY Change 25.89% 25.79%
Operating Profit $8.370M $5.400M
YoY Change 55.0% 45.4%
Interest Expense $200.0K $100.0K
YoY Change 100.0% 1900.0%
% of Operating Profit 2.39% 1.85%
Other Income/Expense, Net $485.0K $0.00
YoY Change -100.0%
Pretax Income $8.817M $5.449M
YoY Change 61.81% 48.15%
Income Tax $1.479M $203.0K
% Of Pretax Income 16.77% 3.73%
Net Earnings $7.338M $5.246M
YoY Change 39.88% 94.58%
Net Earnings / Revenue 10.63% 9.64%
Basic Earnings Per Share $0.35 $0.26
Diluted Earnings Per Share $0.33 $0.25
COMMON SHARES
Basic Shares Outstanding 20.75M 20.16M
Diluted Shares Outstanding 22.00M 21.18M

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $163.1M $108.3M
YoY Change 50.6% 46.15%
Cash & Equivalents $129.7M $86.01M
Short-Term Investments $33.40M $22.30M
Other Short-Term Assets $3.600M $1.900M
YoY Change 89.47% -75.95%
Inventory $16.90M $16.50M
Prepaid Expenses
Receivables $34.70M $29.70M
Other Receivables $1.600M $1.600M
Total Short-Term Assets $219.8M $158.1M
YoY Change 39.03% 38.2%
LONG-TERM ASSETS
Property, Plant & Equipment $21.00M $26.80M
YoY Change -21.64% -15.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.10M $9.600M
YoY Change 161.46% -13.51%
Total Long-Term Assets $50.00M $53.21M
YoY Change -6.04% 23.47%
TOTAL ASSETS
Total Short-Term Assets $219.8M $158.1M
Total Long-Term Assets $50.00M $53.21M
Total Assets $269.8M $211.3M
YoY Change 27.68% 34.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.03M $10.21M
YoY Change 8.02% -28.57%
Accrued Expenses $11.20M $8.800M
YoY Change 27.27% 91.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K
YoY Change -67.85%
Total Short-Term Liabilities $35.40M $30.20M
YoY Change 17.22% 32.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $12.70M $8.500M
YoY Change 49.41% 2547.98%
Total Long-Term Liabilities $12.70M $8.500M
YoY Change 49.41% 2019.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.40M $30.20M
Total Long-Term Liabilities $12.70M $8.500M
Total Liabilities $48.60M $38.70M
YoY Change 25.58% 40.48%
SHAREHOLDERS EQUITY
Retained Earnings -$17.62M
YoY Change -64.01%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $221.3M $172.6M
YoY Change
Total Liabilities & Shareholders Equity $269.8M $194.8M
YoY Change 38.5% 23.71%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $7.338M $5.246M
YoY Change 39.88% 94.58%
Depreciation, Depletion And Amortization $2.940M $3.420M
YoY Change -14.04% -3.93%
Cash From Operating Activities $17.38M $9.050M
YoY Change 92.04% -23.63%
INVESTING ACTIVITIES
Capital Expenditures -$1.130M -$370.0K
YoY Change 205.41% -33.93%
Acquisitions
YoY Change
Other Investing Activities -$4.700M -$10.32M
YoY Change -54.46% 65.12%
Cash From Investing Activities -$5.830M -$10.69M
YoY Change -45.46% 56.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.410M 3.080M
YoY Change 10.71% -274.01%
NET CHANGE
Cash From Operating Activities 17.38M 9.050M
Cash From Investing Activities -5.830M -10.69M
Cash From Financing Activities 3.410M 3.080M
Net Change In Cash 14.96M 1.440M
YoY Change 938.89% -55.83%
FREE CASH FLOW
Cash From Operating Activities $17.38M $9.050M
Capital Expenditures -$1.130M -$370.0K
Free Cash Flow $18.51M $9.420M
YoY Change 96.5% -24.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
251000
CY2017Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
414000
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
115000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-196000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
10000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-442000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
71000
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
237000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7575000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-145000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
134018000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
221000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
485000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8817000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4600000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1479000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
172605000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
7338000
ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-934000
CY2017Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
13000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5254000
ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
10319000
ingn Health Care Organization Patient Service Revenue Adjustments
HealthCareOrganizationPatientServiceRevenueAdjustments
3828000
ingn Cumulative Effect Of Change In Accounting Principle
CumulativeEffectOfChangeInAccountingPrinciple
12226000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9257000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
62000
CY2017Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-305000
CY2016Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-297000
CY2017Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
109000
CY2016Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
12000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
717000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9103000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16826000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3481000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-40000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1155000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1421000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2987000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
131000
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
2085000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1856000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
573000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
47486000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
35367000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
23076000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7801000
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
1424000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-11000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
535000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-37000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
25852000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
26321000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9343000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10290000
ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-891000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
224000
ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
8177000
ingn Health Care Organization Patient Service Revenue Adjustments
HealthCareOrganizationPatientServiceRevenueAdjustments
7783000
us-gaap Inventory Write Down
InventoryWriteDown
141000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9220000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
42000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-546000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
600000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
20799000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
112000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2083000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1483000
ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
2682000
ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
4588000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
129000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
328000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4447000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21389000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11377000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9343000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4600000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1379000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1055000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
235000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10722000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5420000
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
23000
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
8000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
36842000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19903000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66106000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86009000
us-gaap Interest Paid
InterestPaid
9000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1164000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-533000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
104000
CY2016Q4 ingn Doubtful Accounts
DoubtfulAccounts
1869000
CY2016Q4 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
6078000
CY2016Q4 ingn Allowances For Sales Returns
AllowancesForSalesReturns
585000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8532000
CY2017Q3 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.772
CY2016Q3 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.728
ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.707
CY2017Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
391000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition, inventory and rental asset valuations and write-downs, accounts receivable allowances for bad debts, returns and adjustments, stock compensation expense, depreciation and amortization, income tax provision and uncertain tax positions, fair value of financial instruments, and fair value of acquired intangible assets and goodwill. Actual results could differ from these estimates.</p></div>
CY2016Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q4 ingn Rental Equipment Allowance
RentalEquipmentAllowance
725000
CY2017Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2154000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
176000
CY2017Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
101000
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
253000
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3014000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1345000
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1364000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1104000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
133000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
526000
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
314000
CY2017Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
13945000
CY2016Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
12382000
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3209000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2152000
CY2017Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
299000
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
191000
CY2017Q3 us-gaap Property Plant And Equipment Salvage Value
PropertyPlantAndEquipmentSalvageValue
0
CY2017Q3 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
463000
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1930000
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2835000
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3388000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9004000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10217000
CY2017Q3 ingn Rental Equipment Allowance
RentalEquipmentAllowance
808000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
472000
CY2017Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
6999000
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4290000
CY2017Q3 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
2610000
CY2016Q4 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
1760000
CY2017Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
582000
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
281000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1143000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
726000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1244871
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1024899
ingn Patients Using Portable Oxygen Concentrators
PatientsUsingPortableOxygenConcentrators
0.091
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
33395000
CY2017Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
50670000
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
48533000
CY2017Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
77020000
CY2016Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
39277000
CY2016Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
5041000
CY2017Q3 us-gaap Us Government Agencies Securities At Carrying Value
USGovernmentAgenciesSecuritiesAtCarryingValue
2003000
CY2017Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3117000
CY2016Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
7484000
CY2017Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
39034000
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
39360000
CY2017Q3 ingn Doubtful Accounts
DoubtfulAccounts
1920000
CY2017Q3 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
1593000
CY2017Q3 ingn Allowances For Sales Returns
AllowancesForSalesReturns
822000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4335000
ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.752
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
154581
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
761916
CY2017Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M1D
CY2016 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
38.95
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11401000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1961080
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1166512
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1907844
ingn Share Based Compensation Arrangement By Share Based Payment Award Per Share Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerSharePriceGranted
83.30
ingn Share Based Compensation Arrangement By Share Based Payment Award Per Share Price Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerSharePriceExpired
8.70
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.22
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
83.30
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
23.48
CY2016Q3 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
497000
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1808000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
390000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
125000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11033000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5738000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1209696
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1014401
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
160281
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1357794
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2355527
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
64498
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
395739
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
63173
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
33
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
43.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.70
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.49
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
22.89
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
30.20
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y7M17D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y9M26D
ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
64.61
CY2017Q3 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Exercisable Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExercisablePerShareAverageIntrinsicValue
72.21
CY2017Q3 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Expected To Vest Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExpectedToVestPerShareAverageIntrinsicValue
64.90
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17607000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2523000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1953000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6630000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5404000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
309000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1315000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1419000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1031000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
532000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
800000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5406000
CY2017Q3 ingn Related Party Leases Future Minimum Payments Remainder Of Fiscal Year
RelatedPartyLeasesFutureMinimumPaymentsRemainderOfFiscalYear
8000
CY2017Q3 ingn Related Party Leases Future Minimum Payments Due In Two Years
RelatedPartyLeasesFutureMinimumPaymentsDueInTwoYears
32000
CY2017Q3 ingn Related Party Leases Future Minimum Payments Due In Three Years
RelatedPartyLeasesFutureMinimumPaymentsDueInThreeYears
32000
CY2017Q3 ingn Related Party Leases Future Minimum Payments Due In Four Years
RelatedPartyLeasesFutureMinimumPaymentsDueInFourYears
10000
CY2017Q3 ingn Related Party Leases Future Minimum Payments Due
RelatedPartyLeasesFutureMinimumPaymentsDue
82000
CY2017Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
144000
CY2017Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
578000
CY2017Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
578000
CY2016Q3 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
4
CY2017Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
578000
CY2017Q3 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
456000
CY2017Q3 us-gaap Contractual Obligation
ContractualObligation
2334000
CY2017Q3 ingn Operating Leases Related Party Leases And Non Cancelable Contractual Obligations Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesRelatedPartyLeasesAndNonCancelableContractualObligationsFutureMinimumPaymentsRemainderOfFiscalYear
461000
CY2017Q3 ingn Operating Leases Related Party Leases And Non Cancelable Contractual Obligations Minimum Payments Due In Two Years
OperatingLeasesRelatedPartyLeasesAndNonCancelableContractualObligationsMinimumPaymentsDueInTwoYears
1925000
CY2017Q3 ingn Operating Leases Related Party Leases And Non Cancelable Contractual Obligations Minimum Payments Due In Three Years
OperatingLeasesRelatedPartyLeasesAndNonCancelableContractualObligationsMinimumPaymentsDueInThreeYears
2029000
CY2017Q3 ingn Operating Leases Related Party Leases And Non Cancelable Contractual Obligations Minimum Payments Due In Four Years
OperatingLeasesRelatedPartyLeasesAndNonCancelableContractualObligationsMinimumPaymentsDueInFourYears
1619000
CY2017Q3 ingn Operating Leases Related Party Leases And Non Cancelable Contractual Obligations Minimum Payments Due In Five Years
OperatingLeasesRelatedPartyLeasesAndNonCancelableContractualObligationsMinimumPaymentsDueInFiveYears
988000
CY2017Q3 ingn Operating Leases Related Party Leases And Non Cancelable Contractual Obligations Minimum Payments Due Thereafter
OperatingLeasesRelatedPartyLeasesAndNonCancelableContractualObligationsMinimumPaymentsDueThereafter
800000
CY2017Q3 ingn Operating Leases Related Party Leases And Non Cancelable Contractual Obligations Minimum Payments Due
OperatingLeasesRelatedPartyLeasesAndNonCancelableContractualObligationsMinimumPaymentsDue
7822000
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
289000
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
263000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
829000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
766000
CY2017Q3 us-gaap Purchase Obligation
PurchaseObligation
36800000
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3480000
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1973000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3811000
CY2016 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3123000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
200000
CY2016 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
118000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1924000
CY2016 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1734000
CY2017Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5567000
CY2017Q3 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
15
CY2016Q3 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
14
CY2017Q3 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
3

Files In Submission

Name View Source Status
0001564590-17-022249-index-headers.html Edgar Link pending
0001564590-17-022249-index.html Edgar Link pending
0001564590-17-022249.txt Edgar Link pending
0001564590-17-022249-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ingn-10q_20170930.htm Edgar Link pending
ingn-20170930.xml Edgar Link completed
ingn-20170930.xsd Edgar Link pending
ingn-20170930_cal.xml Edgar Link unprocessable
ingn-20170930_def.xml Edgar Link unprocessable
ingn-20170930_lab.xml Edgar Link unprocessable
ingn-20170930_pre.xml Edgar Link unprocessable
ingn-ex101_338.htm Edgar Link pending
ingn-ex102_342.htm Edgar Link pending
ingn-ex103_341.htm Edgar Link pending
ingn-ex104_339.htm Edgar Link pending
ingn-ex105_340.htm Edgar Link pending
ingn-ex311_8.htm Edgar Link pending
ingn-ex312_6.htm Edgar Link pending
ingn-ex321_9.htm Edgar Link pending
ingn-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending